“…KX2-329, a biaryl-based, non-ATPcompetitive Src inhibitor, and also a tubulin polymerization inhibitor, significantly reduced threshold shifts at 24 h, one week and four weeks after the noise exposure, and also reduced noiseinduced OHC loss. KX2-328, an ATP-competitive Src inhibitor [53], was not effective in reducing NIHL. Overall, the data indicated that the biaryl-based, non-ATP-competitive Src inhibitor KX2-329 was capable of significantly reducing NIHL when present in the cochlea.…”